ArticleClinical case reports2026
Photobiomodulation and Radio-Epithelitis in Anal Carcinoma: A Case-Report and Clinical Reflection on Emerging Preventive and Supportive Care Modalities.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radio-induced dermatitis, a frequent adverse effect of radiation therapy, is particularly prevalent in patients treated for anal margin carcinoma. It may present with varying severity, causing significant pain and impairment of daily mobility, influenced by both patient-related factors and treatment regimens. The standard management is challenging, largely topical and supportive, often insufficient to adequately address morbidity in severe or refractory cases. Photobiomodulation therapy using red-light and near-infrared light has been increasingly recognized in oncology supportive care; however, evidence remains limited for perianal radiation-induced skin toxicity and use prior to re-irradiation. We report the case of a 79-year-old woman treated for epidermoid carcinoma of the anal margin who developed grade 2 radiation-induced epithelitis during chemoradiotherapy, refractory to conventional topical treatments. Red-light photobiomodulation therapy (RL-PBMT, 632 nm, 67 mW/cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.